C. Valenta et al., LYSOZYME-CAFFEIC ACID CONJUGATES - POSSIBLE NOVEL PRESERVATIVES FOR DERMAL FORMULATIONS, International journal of pharmaceutics, 174(1-2), 1998, pp. 125-132
An equivalent mixture of a recently developed lysozyme-caffeic acid co
njugate and lysozyme was tested as possible preservative-system for de
rmal products. Whereas bacterial growth of Escherichia coli (ATCC 8793
) was strongly inhibited by the lysozyme-caffeic acid conjugate, the e
fficacy towards Staphylococcus aureus (ATCC 6538) was slightly reduced
. In order to compensate for this effectivity loss, a combination of l
ysozyme-caffeic acid conjugate and lysozyme was required. Microbial ef
ficacy was studied in Various hydrogels based on the following polymer
s: hydroxypropylmethylcellulose (HPMC), sodium chitosan-EDTA (NaChito-
EDTA) and sodium carbopol 980 (NaC980), and the effectiveness as a pre
servative tested with E. coli as Gram-negative and S. aureus as Gram-p
ositive representatives. Colony forming units (cfu) of samples were co
unted immediately and 1, 7, 14, 21 and 28 days after inoculation. The
effectiveness of the preservative-system depended on the polymer type,
the bacterial strains (Gram-negative or Gram-positive) and on the app
lied concentration. Almost no antibacterial effect could be detected i
n NaC980 gels, which may be caused by the attachment of lysozyme to th
e polymer. Our results show that a concentration of 0.2% (w/w) of the
lysozyme-caffeic acid conjugate/lysozyme mixture (1+1) was required fo
r HPMC- and NaChito-EDTA gels to exert a bactericidal effect for Gram-
negative as well as for Gram-positive bacteria with the exception of H
PMC gels towards E. coli, where only a bacteriostatic effect could be
detected at this concentration. (C) 1998 Elsevier Science B.V. All rig
hts reserved.